Orange Book product · Generic (ANDA)
GLIMEPIRIDE
GLIMEPIRIDE
At a glance
Dec 23, 2005
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 23, 2005
20 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
GLIMEPIRIDE
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 077370
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of GLIMEPIRIDE
- 1995AMARYLBrand (NDA)
NDA 020496 · SANOFI AVENTIS US
- 2013GLIMEPIRIDEGeneric (ANDA)
ANDA 078952 · HIKMA PHARMS
- 2013GLIMEPIRIDEGeneric (ANDA)
ANDA 202112 · REGCON HOLDINGS
- 2012GLIMEPIRIDEGeneric (ANDA)
ANDA 202759 · AUROBINDO PHARMA LTD
- 2012GLIMEPIRIDEGeneric (ANDA)
ANDA 091220 · MICRO LABS
- 2010GLIMEPIRIDEGeneric (ANDA)
ANDA 076995 · ACTAVIS LABS FL INC
- 2009GLIMEPIRIDEGeneric (ANDA)
ANDA 077911 · CARLSBAD
- 2007GLIMEPIRIDEGeneric (ANDA)
ANDA 078181 · ACCORD HLTHCARE
- 2006GLIMEPIRIDEGeneric (ANDA)
ANDA 077486 · MYLAN
- 2006GLIMEPIRIDEGeneric (ANDA)
ANDA 077280 · WATSON LABS
- 2005GLIMEPIRIDEGeneric (ANDA)
ANDA 077624 · QUAGEN
- 2005GLIMEPIRIDEGeneric (ANDA)
ANDA 077295 · CHARTWELL MOLECULAR
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
